Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Gabriel S Tajeu

Biographic Data

ID5121261
NAMEGabriel S Tajeu
GIVEN NAMESGabriel S
FAMILY NAMETajeu
SIGNATURETAJEU G S
AFFILIATIONSEpidemiology
ORCID0000-0002-9982-5250
VERIFIEDYes
TOTAL WORKS3
TOTAL CITATIONS6
WORKS AS AUTHOR3
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2015
LATEST PUBLICATION YEAR2020
H-INDEX2
  • Black–White Differences in Cardiovascular Disease Mortality

    Gabriel S Tajeu, Monika M Safford et al.•ARTICLE•American Journal of Public Health•2020•Cited by: 2•References: 35

    Objectives. To determine factors that explain the higher Black:White cardiovascular disease (CVD) mortality rates among US adults. Methods. We analyzed data from the Reasons for Geographic and Racial Differences in Stroke study from 2003 to 2017 to estimate Black:White hazard ratios (HRs) for CVD mortality within subgroups younger than 65 years and aged 65 years or older. Results. Among 29 054 participants, 41.0% who were Black and 54.9% who were…

  • Cost-effectiveness of Antihypertensive Medication

    Gabriel S Tajeu, Stephen Mennemeyer et al.•ARTICLE•Medical Care•2017•References: 42

    BACKGROUND: Antihypertensive medication decreases risk of cardiovascular disease (CVD) events in adults with hypertension. Although black adults have higher prevalence of hypertension and worse CVD outcomes compared with whites, limited attention has been given to the cost-effectiveness of antihypertensive medication for blacks. OBJECTIVE: To compare the cost-effectiveness of antihypertensive medication treatment versus no-treatment in white and …

  • We’ll Get to You When We Get to You”

    Gabriel S Tajeu, Andrea Cherrington et al.•ARTICLE•American Journal of Public Health•2015•Cited by: 4•References: 26

    Objectives. We qualitatively assessed patients’ perceptions of discrimination and patient satisfaction in the health care setting specific to interactions with nonphysician health care staff. Methods. We conducted 12 focus-group interviews with African American and European American participants, stratified by race and gender, from June to November 2008. We used a topic guide to facilitate discussion and identify factors contributing to perceived…

  • We’ll Get to You When We Get to You”

    Gabriel S Tajeu, Andrea Cherrington et al.•ARTICLE•American Journal of Public Health•2015•Cited by: 4•References: 26

    Objectives. We qualitatively assessed patients’ perceptions of discrimination and patient satisfaction in the health care setting specific to interactions with nonphysician health care staff. Methods. We conducted 12 focus-group interviews with African American and European American participants, stratified by race and gender, from June to November 2008. We used a topic guide to facilitate discussion and identify factors contributing to perceived…

  • Black–White Differences in Cardiovascular Disease Mortality

    Gabriel S Tajeu, Monika M Safford et al.•ARTICLE•American Journal of Public Health•2020•Cited by: 2•References: 35

    Objectives. To determine factors that explain the higher Black:White cardiovascular disease (CVD) mortality rates among US adults. Methods. We analyzed data from the Reasons for Geographic and Racial Differences in Stroke study from 2003 to 2017 to estimate Black:White hazard ratios (HRs) for CVD mortality within subgroups younger than 65 years and aged 65 years or older. Results. Among 29 054 participants, 41.0% who were Black and 54.9% who were…

  • We’ll Get to You When We Get to You”

    Gabriel S Tajeu, Andrea Cherrington et al.•ARTICLE•American Journal of Public Health•2015•Cited by: 4•References: 26

    Objectives. We qualitatively assessed patients’ perceptions of discrimination and patient satisfaction in the health care setting specific to interactions with nonphysician health care staff. Methods. We conducted 12 focus-group interviews with African American and European American participants, stratified by race and gender, from June to November 2008. We used a topic guide to facilitate discussion and identify factors contributing to perceived…

  • Cost-effectiveness of Antihypertensive Medication

    Gabriel S Tajeu, Stephen Mennemeyer et al.•ARTICLE•Medical Care•2017•References: 42

    BACKGROUND: Antihypertensive medication decreases risk of cardiovascular disease (CVD) events in adults with hypertension. Although black adults have higher prevalence of hypertension and worse CVD outcomes compared with whites, limited attention has been given to the cost-effectiveness of antihypertensive medication for blacks. OBJECTIVE: To compare the cost-effectiveness of antihypertensive medication treatment versus no-treatment in white and …

  • Black–White Differences in Cardiovascular Disease Mortality

    Gabriel S Tajeu, Monika M Safford et al.•ARTICLE•American Journal of Public Health•2020•Cited by: 2•References: 35

    Objectives. To determine factors that explain the higher Black:White cardiovascular disease (CVD) mortality rates among US adults. Methods. We analyzed data from the Reasons for Geographic and Racial Differences in Stroke study from 2003 to 2017 to estimate Black:White hazard ratios (HRs) for CVD mortality within subgroups younger than 65 years and aged 65 years or older. Results. Among 29 054 participants, 41.0% who were Black and 54.9% who were…

Medicine (3 works) · Demography (2 works) · Gerontology (2 works) · Gerontology (2 works) · Internal Medicine (2 works) · Internal Medicine (2 works) · Association (psychology) (1 work) · Blood Pressure and Hypertension Studies (1 work) · Cardiovascular Health and Risk Factors (1 work) · Climate Change and Health Impacts (1 work)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae